Skip to main content
Equibles

Ikarian Capital, LLC

Position in VIR — Vir Biotechnology, Inc.

CIK 1778253 DALLAS, TX
Back to VIR Full portfolio

Position in VIR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$2,627,591
-$843,952 QoQ
Shares Held
293,258
-49.1% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Derivatives in VIR

reported options exposure · as of Dec 31, 2024
CallValue
$5,287,002
CallShares
720,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in VIR

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,627,591 293,258
2025-12-31 $3,471,543 575,712
2025-09-30 $3,388,165 593,374
2025-06-30 $5,383,032 1,068,062
2025-03-31 $6,921,041 1,068,062
2024-12-31 $5,287,002 720,300
2024-12-31 $6,590,307 897,862
2021-03-31 $12,817,500 250,000
2020-12-31 $7,177,040 268,000